Concepts (99)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dengue | 8 | 2022 | 93 | 2.440 |
Why?
|
| Fever | 7 | 2022 | 57 | 2.050 |
Why?
|
| Influenza, Human | 5 | 2022 | 79 | 1.220 |
Why?
|
| Pregnancy Complications, Infectious | 3 | 2022 | 99 | 1.060 |
Why?
|
| Puerto Rico | 20 | 2022 | 1352 | 1.060 |
Why?
|
| Microcephaly | 1 | 2022 | 18 | 0.860 |
Why?
|
| Leukopenia | 2 | 2017 | 9 | 0.580 |
Why?
|
| Child, Preschool | 8 | 2022 | 1318 | 0.560 |
Why?
|
| Dengue Virus | 5 | 2022 | 84 | 0.560 |
Why?
|
| Infant | 7 | 2022 | 1014 | 0.550 |
Why?
|
| Child | 11 | 2022 | 2875 | 0.530 |
Why?
|
| Adolescent | 14 | 2021 | 5035 | 0.490 |
Why?
|
| Population Surveillance | 5 | 2020 | 231 | 0.490 |
Why?
|
| Immunoglobulin M | 2 | 2021 | 81 | 0.390 |
Why?
|
| Antibodies, Viral | 3 | 2023 | 252 | 0.390 |
Why?
|
| Age Distribution | 3 | 2018 | 223 | 0.340 |
Why?
|
| Infant, Newborn | 3 | 2022 | 871 | 0.340 |
Why?
|
| Humans | 25 | 2023 | 34853 | 0.340 |
Why?
|
| Hospitalization | 4 | 2021 | 370 | 0.340 |
Why?
|
| Young Adult | 10 | 2021 | 4012 | 0.330 |
Why?
|
| Female | 16 | 2022 | 19873 | 0.320 |
Why?
|
| Chikungunya virus | 3 | 2023 | 16 | 0.310 |
Why?
|
| Adult | 13 | 2022 | 11034 | 0.300 |
Why?
|
| RNA, Viral | 2 | 2019 | 287 | 0.300 |
Why?
|
| Male | 15 | 2022 | 18870 | 0.280 |
Why?
|
| Diagnosis, Differential | 2 | 2019 | 211 | 0.270 |
Why?
|
| Disease Outbreaks | 2 | 2016 | 155 | 0.260 |
Why?
|
| Predictive Value of Tests | 2 | 2019 | 424 | 0.260 |
Why?
|
| Emergency Service, Hospital | 2 | 2020 | 188 | 0.260 |
Why?
|
| Pregnancy | 5 | 2022 | 1503 | 0.250 |
Why?
|
| Middle Aged | 10 | 2021 | 9642 | 0.250 |
Why?
|
| Renal Insufficiency | 1 | 2022 | 18 | 0.220 |
Why?
|
| Amyloidosis | 1 | 2022 | 33 | 0.220 |
Why?
|
| Respiratory Syncytial Virus, Human | 1 | 2022 | 7 | 0.220 |
Why?
|
| Neurologic Examination | 1 | 2022 | 31 | 0.220 |
Why?
|
| Hospitals | 2 | 2020 | 86 | 0.220 |
Why?
|
| Prospective Studies | 4 | 2020 | 1353 | 0.210 |
Why?
|
| Viruses | 1 | 2022 | 35 | 0.210 |
Why?
|
| Tropical Climate | 1 | 2020 | 21 | 0.190 |
Why?
|
| Triclosan | 1 | 2020 | 5 | 0.190 |
Why?
|
| Aged | 7 | 2022 | 6448 | 0.190 |
Why?
|
| Infertility, Female | 1 | 2020 | 24 | 0.190 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2021 | 445 | 0.190 |
Why?
|
| Viral Load | 2 | 2019 | 300 | 0.190 |
Why?
|
| Sex Distribution | 2 | 2017 | 212 | 0.190 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2019 | 22 | 0.180 |
Why?
|
| Cyclonic Storms | 1 | 2020 | 62 | 0.170 |
Why?
|
| Semen | 1 | 2019 | 48 | 0.170 |
Why?
|
| Cohort Studies | 1 | 2022 | 1422 | 0.160 |
Why?
|
| Headache | 1 | 2017 | 18 | 0.160 |
Why?
|
| Thrombocytopenia | 1 | 2017 | 21 | 0.160 |
Why?
|
| Acute Disease | 1 | 2017 | 141 | 0.150 |
Why?
|
| Aged, 80 and over | 3 | 2017 | 2333 | 0.150 |
Why?
|
| Time Factors | 2 | 2018 | 1681 | 0.140 |
Why?
|
| Incidence | 4 | 2021 | 882 | 0.140 |
Why?
|
| Polymerase Chain Reaction | 2 | 2018 | 430 | 0.130 |
Why?
|
| Retrospective Studies | 4 | 2022 | 1961 | 0.130 |
Why?
|
| Chronic Disease | 1 | 2017 | 469 | 0.120 |
Why?
|
| Alzheimer Disease | 1 | 2020 | 881 | 0.120 |
Why?
|
| Cross-Sectional Studies | 4 | 2022 | 2561 | 0.110 |
Why?
|
| Capillary Fragility | 1 | 2011 | 1 | 0.110 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2011 | 17 | 0.100 |
Why?
|
| Leukocyte Count | 1 | 2011 | 74 | 0.100 |
Why?
|
| Seasons | 2 | 2021 | 112 | 0.090 |
Why?
|
| Public Health Practice | 2 | 2016 | 38 | 0.070 |
Why?
|
| Risk Factors | 2 | 2022 | 3414 | 0.060 |
Why?
|
| Glycoproteins | 1 | 2023 | 100 | 0.050 |
Why?
|
| Antibodies, Neutralizing | 1 | 2023 | 102 | 0.050 |
Why?
|
| Endemic Diseases | 1 | 2021 | 22 | 0.050 |
Why?
|
| Cross Reactions | 1 | 2021 | 83 | 0.050 |
Why?
|
| Serologic Tests | 1 | 2021 | 43 | 0.050 |
Why?
|
| Viral Nonstructural Proteins | 1 | 2021 | 45 | 0.050 |
Why?
|
| Benzophenones | 1 | 2020 | 7 | 0.050 |
Why?
|
| Parabens | 1 | 2020 | 7 | 0.050 |
Why?
|
| Influenza A virus | 1 | 2020 | 25 | 0.050 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2020 | 47 | 0.050 |
Why?
|
| Chi-Square Distribution | 1 | 2020 | 213 | 0.040 |
Why?
|
| Neuropsychological Tests | 1 | 2020 | 255 | 0.040 |
Why?
|
| Nutrition Surveys | 1 | 2020 | 228 | 0.040 |
Why?
|
| Vero Cells | 1 | 2019 | 90 | 0.040 |
Why?
|
| Specimen Handling | 1 | 2019 | 49 | 0.040 |
Why?
|
| Age Factors | 1 | 2021 | 1007 | 0.040 |
Why?
|
| Sex Factors | 1 | 2021 | 859 | 0.040 |
Why?
|
| Wounds and Injuries | 1 | 2020 | 166 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 555 | 0.040 |
Why?
|
| Pregnant Women | 1 | 2018 | 48 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2019 | 322 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2021 | 1349 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2019 | 605 | 0.040 |
Why?
|
| Virus Replication | 1 | 2019 | 261 | 0.040 |
Why?
|
| Blood Donors | 1 | 2016 | 17 | 0.040 |
Why?
|
| Prevalence | 1 | 2021 | 1425 | 0.040 |
Why?
|
| Family Characteristics | 1 | 2016 | 102 | 0.030 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2020 | 375 | 0.030 |
Why?
|
| Animals | 2 | 2023 | 14307 | 0.030 |
Why?
|
| Anxiety | 1 | 2020 | 705 | 0.030 |
Why?
|
| Residence Characteristics | 1 | 2016 | 301 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2019 | 2128 | 0.030 |
Why?
|
| United States | 1 | 2020 | 3894 | 0.020 |
Why?
|